Silverarc Capital Management’s LAVA Therapeutics LVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-140,291	Closed	-$233K	–	85
2023 Q1	$233K	Sell	140,291 -297,471	-68%	-$494K	0.1%	63
2022 Q4	$1.53M	Sell	437,762 -173,047	-28%	-$606K	0.44%	51
2022 Q3	$2.79M	Buy	+610,809	New	+$2.79M	0.94%	30